A Mathematical Model of Alzheimer's Disease and the Apoe Gene

ASTIN Bulletin

Volumn 30, Issue 1, 2000, Pages 69-110

  Macdonald, Angus ^a   Pritchard, Delme ^a  

^a HERIOT WATT UNIVERSITY   (United Kingdom)

Author keywords

Alzheimer's Disease; Apolipoprotein E Gene; Genetics; Markov Models

Indexed keywords

EID: 85011453516     PISSN: 05150361     EISSN: 17831350     Source Type: Journal    
DOI: 10.2143/AST.30.1.504627     Document Type: Article

References (96)

1. Barclay, L.L., Zemcov, A., Blass, J.P. and McDowell, F.H. (1985a) Factors associated with duration of survival in Alzheimer's disease. Biological Psychiatry. 20, 86–93.
2. Barclay, L.L., Zemcov, A., Blass, J.P. and Sansone, J. (1985b) Survival in Alzheimer's disease and vascular dementias. Neurology. 35, 834–840.
3. Basun, H., Grut, M., Winblad, B. and Lannfeldt, L. (1995) Apolipoprotein ϵ4 allele and disease progression in patients with late onset Alzheimer's disease. Neuroscience Letters. 183, 32–34.
4. Beard, C.M., Kokmen, E., O'Brien, P.C. and Kurland, L.T. (1994) Are patients with Alzheimer's disease surviving longer in recent years? Neurology. 44, 1869–1871.
5. Berg, L., Miller, J.P., Storandt, M., Duchek, J., Morris, J.C., Rubin, E.H., Burke, W.J. and Coben, L.A. (1988) Mild senile dementia of the Alzheimer type: 2. Longitudinal assessment. Annals of Neurology. 23, 477–484.
6. Bickeböller, H., Campion, D., Brice, A., Amouyel, P., Hannequin, D., Didierjean, O., Penet, C., Martin, C., Pérez-Tur, J., Michon, A., Dubois, B., Ledoze, F., Thomas-Anterion, C., Pasquier, F., Puel, M., Demonet, J-F., Moreaud, O., Babron, M-C., Meulien, D., Guez, D., Chartier-Harlin, M-C., Frebourg, T., Agid, Y., Martinez, M. and Clerget-Darpoux, F. (1997) Apolipoprotein E and Alzheimer's disease: genotypespecific risks by age and sex. American Journal of Human Genetics. 60, 439–446.
7. Bonaiuto, S., Mele, M., Galluzo, L. and Giannandrea, E. (1995) Survival and dementia: A 7-year follow up of an Italian population. Archives of Gerontology and Geriatrics. 20, 105–113.
8. Bracco, L., Gallato, R., Grigoletto, F., Lippi, A., Lepore, V., Bino, G., Lazzaro, M.P., Carella, F., Piccolo, T., Pozzilli, C., Giometto, B. and Amaducci, L. (1994) Factors affecting course and survival in Alzheimer's disease. Archives of Neurology. 51, 1213–1219.
9. Breteler, M.B.B., Claus, J.J., Van Duijn, C.M., Launer, L.J. and Hofman, A. (1992) Epidemiology of Alzheimer's disease. Epidemiologic Reviews. 14, 59–82.
10. Brindle, N., Song, Y., Rogaeva, E., Premkumar, S., Levesque, G., Yu, G., Ikeda, M., Nishimura, M., Paterson, A., Sorbi, S., Duara, R., Farrer, L. and St George-Hyslop, P. (1998) Analysis of the butyrycholinesterase gene and nearby chromosome 3 markers in Alzheimer's disease. Human Molecular Genetics. 7, 933–935.
11. Burns, A., Lewis, G., Jacoby, R. and Levy, R. (1991) Factors affecting survival in Alzheimer's disease. Psychological Medicine. 21, 363–370.
12. Clayton, D. and Hills, M. (1993) Statistical methods in epidemiology. Oxford University Press.
13. Conte, S.D. and De Boor, C. (1972) Elementary numerical analysis. McGraw-Hill, New York.
14. Copeland, J.R.M., Davidson, I.A., Dewey, M.E., Gilmore, C., Larkin, B.A., McWilliam, C., Saunders, P.A., Scott, A., Sharma, V. and Sullivan, C. (1992) Alzheimer's disease, other dementias, depression and pseudo-dementia: prevalence, incidence and three-year outcome in Liverpool. British Journal of Psychiatry. 161, 230–239.
15. Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Rimmler, J.B., Locke, P.A., Conneally, P.M., Schmader, K.E., Small, G.W., Roses, A.D., Haines, J.L. and Pericak-Vance, M.A. (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer's disease. Nature Genetics. 7, 180–184.
16. Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Rimmler, J.B., Locke, P.A., Conneally, P.M., Schmader, K.E., Tanzi, R.E., Gusella, J.F., Small, G.W., Roses, A.D., Pericak-Vance, M.A. and Haines, J.L. (1995) Apolipoprotein E, survival in Alzheimer's disease and the competing risks of death and Alzheimer's disease. Neurology. 45, 1323–1328.
17. Diesfeldt, H.F.A., Van Houte, L.R. and Moerkens, R.M. (1986) Duration of survival in senile dementia. Acta Psychiatr Scandinavica. 73, 366–371.
18. Van Dijk, P.T.M., Dippel, D.W.J., and Habbema, J., Dijk, F. (1991) Survival of patients with dementia. Journal of the American Geriatric Society. 39, 603–610.
19. Van Duijn, C.M., de Kniff, P., Wehnert, A., De Voecht, J., Bronzova, J.B., Havekes, L.M., Hofman, A. and Van Broeckhoven, C. (1995) The apolipoprotein E ϵ4 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Annals of Neurology. 37, 605–610.
20. Evans, D.A., Funkenstein, H., Albert, M.S., Scherr, P.A., Cook, N.R., Chown, M.J., Hebert, L.E., Hennekens, C.H. and Taylor, J.O. (1989) Prevalence of Alzheimer's disease in a community population of older persons: Higher than previously reported. Journal of the American Medical Association. 262, 2551–2556.
21. Evans, D.A., Smith, L.A., Scherr, P.A., Albert, M.S., Funkenstein, H.H. and Hebert, L.E. (1991) Risk of death from Alzheimer's disease in a community population of older persons. American Journal of Epidemiology. 134, 403–412.
22. Evans, D.A., Beckett, L.A., Field, T.S., Feng, L., Albert, M.S., Bennett, D.A., Tycko, B. and Mayeux, R. (1997) Apolipoprotein E e4 and incidence of Alzheimer's disease in a community population of elder persons. Journal of the American Medical Association. 211, 822–824.
23. Farrer, L.A., Cupples, L.A., Haines, J.L., Hyman, B., Kukull, W.A., Mayeux, R., Myers, R.H., Pericak-Vance, M.A., Risch, N., Van Duijn, C.M. and Apoe and Alzheimer Disease Meta Analysis Consortium (1997) Effects of age, gender and ethnicity on the association between apolipoprotein E genotype and Alzheimer's disease. Journal of the American Medical Association. 278, 1349–1356.
24. Forfar, D.O., McCutcheon, J.J. and Wilkie, A.D. (1988) On graduation by mathematical formula. J.I.A. 115, 1–149 and (with discussion) T.F.A. 41, 97–269.
25. Friedman, L.M., Furberg, C.D. and Demets, D.L. (1998) Fundamentals of clinical trials. Springer-Verlag, New York.
26. Frisoni, G.B., Govoni, S., Geroldi, C., Bianchetti, A., Calabres, L., Franceschini, G. and Trabucchi, M. (1995) Gene dose of the ϵ4 allele of apolipoprotein E and disease progression in sporodic late onset Alzheimer's disease. Annals of Neurology. 37, 596–604.
27. Gao, S., Hendrie, H.C., Hall, K.S. and Hui, S. (1998) The relationship between age, sex and the incidence of dementia and Alzheimer's disease. Archives of General Psychiatry. 55, 809–815.
28. Gomez-Isla, T., West, H.L., Rebeck, G.W., Harr, S.D., Gowdon, J.H., Locascio, J.J., Perls, T.T., Lepsitz, L.A. and Hyman, B.T. (1996) Clinical and pathological correlates of apolipoprotein E ϵ4 in Alzheimer's disease. Annals of Neurology. 39, 62–70.
29. Green, S., Benedetti, J. and Crowley, J. (1997) Clinical trials in oncology. Chapman and Hall, London.
30. Hagnell, O., Ojesjo, L. and Rorsman, B. (1992) Incidence of dementia in the Lundby study. Neuroepidemiology. 11, 61–66.
31. Hebert, L.E., Scherr, P.A., Beckett, L.A., Albert, M.S., Pilgrim, D.M., Chown, M.J., Funkenstein, H.H. and Evans, D.A. (1995) Age specific incidence of Alzheimer's disease in a community population. Journal of the American Medical Association. 273, 1354–1359.
32. Heyman, A., Peterson, B., Fillenbaum, G. and Pieper, C. (1996) The consortium to establish a registry for Alzheimer's disease (CERAD) Part XIV: Demographic and clinical predictors of survival in patients with Alzheimer's disease. Neurology. 46, 656–660.
33. Heyman, A., Peterson, B., Fillenbaum, G. and Pieper, C. (1997) Predictors of time to institutionalization of patients with Alzheimer's disease: the CERAD experience part XVII. Neurology. 48, 1304–1309.
34. Jarvik, G.P., Larson, E.B., Goddard, K., Kukull, W.A., Schellenberg, G.D. and Wijsman, E.M. (1996) Influence of apolipoprotein E genotype on the transmission of Alzheimer's disease in a community-based sample. American Journal of Human Genetics. 58, 191–200.
35. Jorm, A.F. and Jolley, D. (1998) The incidence of dementia – a meta analysis. Neurology. 51, 728–733.
36. Jost, B.C. and Grossberg, G.T. (1995) The natural history of Alzheimer's disease: a brain bank study. Journal of the American Geriatrics Society. 43, 1248–1255.
37. Kahn, H. and Sempos, C.T. (1989) Statistical methods in epidemiology. Oxford University Press.
38. Kokmen, E., Chandra, V. and Schoenberg, B. (1988) Trends in incidence of dementing illness in Rochester, Minnesota, in three quinquennial periods, 1960–1974. Neurology. 38, 975–980.
39. Kokmen, E., Beard, R.N., O'Brien, P.C., Offord, M.S. and Kurland, L.T. (1993) Is the incidence of dementing illness changing? Neurology. 43, 1887–1892.
40. Kuusisto, J., Koivisto, K., Mykkänen, L., Helkala, E-L., Vanhanen, M., Hänninen, T., Pyörälä, K., Kesäniemi, Y.A., Riekkinon, P. and Laakso, K. (1994) Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. British Medical Journal. 309, 636–638.
41. Lambert, J-C., Pasquier, F., Cottel, D., Frigard, B., Amouyel, P. and Chartier-Harlin, M-C. (1998) A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease, Human Molecular Genetics. 7, 533–540.
42. Lehmann, D.J., Johnston, C. and Smith, A.D. (1997) Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease. Human Molecular Genetics. 6, 1933–1936.
43. Lehtovirta, M., Helisalmi, S., Mannermaa, A., Soininen, H., Koivisto, K., Ryynänen, M. and Riekkinen, Sr P. (1995) Apolipoprotein E polymorphism and Alzheimer's disease in Eastern Finland. Neuroscience Letters. 185, 13–15.
44. Lemaire, J., Subramanian, K., Armstrong, K. and Asch, D.A. (2000) Pricing term insurance in the presence of a family history of breast or ovarian cancer. To appear in North American Actuarial Journal.
45. Letenneur, L., Commences, D., Dartigues, J.F. and Barbergergateau, P. (1994) Incidence of dementia and Alzheimer's disease in elderly community residents of southwestern France. International Journal of Epidemiology. 23, 1256–1261.
46. Levy-Lahad, E. and Bird, T.D. (1996) Genetic factors in Alzheimer's disease: a review of recent advances. Annals of Neurology. 40, 829–840.
47. Liddell, M., Williams, J., Bayer, A., Kaiser, F. and Owen, M. (1994) Confirmation of association between the ϵ4 allele of apolipoprotein E and Alzheimer's disease. Journal of Medical Genetics. 31, 197–200.
48. Lilienfeld, D.E. and Stolley, P.D. (1994) Foundations of epidemiology. Oxford University Press.
49. Lopez, O.L., Lopez-Pousa, S., Kamboh, M.I., Adroer, R., Oliva, R., Lozano-Gallego, M., Becker, T.B. and Dekosky, S.T. (1998) Apolipoprotein E polymorphism in Alzheimer's disease: a comparative study of two research populations from Spain and the United States. European Neurology. 39, 229–233.
50. Lucotte, G., David, F., Legrand, C., Turpin, J-C. and Clavel, C. (1997) Predictive value of apolipoprotein E ϵ4 allele genotyping in Alzheimer's disease. Alzheimer's Research. 3, 7–9.
51. Macdonald, A.S. (1996a) An actuarial survey of statistical models for decrement and transition data I: Multiple state, Poisson and binomial models. British Actuarial Journal. 2, 129–155.
52. Macdonald, A.S. (1996b) An actuarial survey of statistical models for decrement and transition data III: Counting process models. British Actuarial Journal. 2, 703–726.
53. Macdonald, A.S. (1997) How will improved forecasts of individual lifetimes affect underwriting?. Philosophical Transactions of the Royal Society. B, 352, 1067–1075, and (with discussion) British Actuarial Journal 3, 1009–1025 and 1044–1058.
54. Macdonald, A.S. (1999) Modeling the impact of genetics on insurance. North American Actuarial Journal. 3: 1, 83–101.
55. Macdonald, A.S. and Pritchard, D.J. (1999) Genetics, Alzheimer's disease and long-term care insurance. Genetics and Insurance Research Report No. 99/2, Department of Actuarial Mathematics and Statistics, Heriot-Watt University, Edinburgh.
56. Massullo, C., Daniele, A., Seripa, D., Filippini, V., Gravina, C., Carbone, G., Gainotti, G. and Fazio, V.M. (1998) Apolipoprotein E genotype in sporadic early- and late-onset Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 9, 121–125.
57. Mayeux, R., Stern, Y., Ottman, R., Tatemichi, T.K., Tang, M-X., Maestre, G., Ngai, C., Tycko, B. and Ginsberg, H. (1993) The apolipoprotein ϵ4 allele in patients with Alzheimer's disease. Annals of Neurology. 34, 752–754.
58. Mölsä, P.K., Marttila, R.J. and Rinnes, U.K. (1982) Epidemiology of dementia in a Finnish population. Acta Neurologica Scandinavica. 65, 541–552.
59. Mölsä, P.K., Marttila, R.J. and Rinnes, U.K. (1986) Survival and cause of death in Alzheimer's disease and multi-infarct dementia. Acta Neurologica Scandinavica. 74, 103–107.
60. Myers, R.H., Schaeffer, E.J., Wilson, P.W.F., D'Agostino, R., Ordovas, J.M., Espino, A., White, R.F., Knoefel, J.E., Cobb, J.L., McNulty, K.A., Beiser, A. and Wolf, P.A. (1996) Apolipoprotein E ϵ4 association with dementia in a population based study: the Framingham study. Neurology. 46, 673–677.
61. Nalbantoglu, J., Gilfix, B.M., Bertrand, P., Robitaille, Y., Gauthier, S., Rosenblatt, D.S. and Poirier, J. (1994) Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies. Annals of Neurology. 36, 889–895.
62. Nilsson, L.V. (1984) Incidence of severe dementia in an urban sample followed from 70 to 79 years of age. Acta Psychiatrica Scandinavica. 70, 478–486.
63. Norberg, R. (1995) Differential equations for moments of present values in life insurance. Insurance: Mathematics and Economics. 17, 171–180.
64. Norrman, J., Brookes, A.J., Yates, C. and Clair, D.S. (1995) Apolipoprotein E genotype and its effect on duration and severity of early and late onset Alzheimer's disease. British Journal of Psychiatry. 167, 533–536.
65. O'Connor, D.W., Pollitt, P.A., Hyde, J.B. et al. (1989) The prevalence of dementia as measured by the Cambridge Mental Disorders of the Elderly Examination. Acta Psychiatrica Scandinavica. 79, 190–198.
66. Ott, A., Breteler, M.M.B., van Harskamp, F., Stijnen, T. and Hofman, A. (1998) Incidence and risk of dementia. American Journal of Epidemiology. 147, 574–580.
67. Payami, H., Schellenberg, G.D., Zareparsi, S., Kaye, J., Sexton, G.J., Head, M.A., Matsuyama, S.S., Jarvik, L.F., Miller, B., McManus, D.Q., Bird, T.D., Katzman, R., Heston, L., Norman, D. and Small, G.W. (1997) Evidence for association of HLA-A2 allele with onset age of Alzheimer's disease. Neurology. 48, 512–518.
68. Pericak-Vance, M.A., Bebout, J.L., Gaskell, P.C., Yamaoka, L.H., Hung, W.Y., Alberts, M.J., Walker, A.P., Bartlett, R.J., Haynes, C.A., Welsh, K.A., Earl, N.L., Heyman, A., Clark, C.M. and Roses, A.D. (1991) Linkage studies in familial Alzheimer's disease: evidence for chromosome 19 linkage. American Journal of Human Genetics. 48, 1034–1050.
69. Pfeffer, R.I., Afifi, A.A. and Chance, J.M. (1987) Prevalence of Alzheimer's disease in a retirement community. American Journal of Epidemiology. 125, 420–436.
70. Piantadosi, S. (1997) Clinical trials: A methodologicperspective. John Wiley and Sons, New York.
71. Poduslo, S.E., Neal, M., Herring, K. and Shelly, J. (1998) The apolipoprotein CI A allele as a risk factor for Alzheimer's disease. Neurochemical Research. 23. 361–367.
72. Poirier, J., Davignon, J., Bouthillier, D., Kogan, S., Bertrand, P. and Gauthier, S. (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 342, 697–699.
73. Pritchard, D.J. (1997) Life assurance: financial implications of a change in insuring behaviour resulting from individuals' increased knowledge of their genetic predispositions. M.Sc. dissertation, Heriot-Watt University, Edinburgh.
74. Rocca, W.A., Cha, R.H., Waring, S.C. and Kokmen, E. (1998) Incidence of dementia and Alzheimer's disease: a reanalysis of data from Rochester, Minnesota, 1975–1984. American Journal of Epidemiology. 148, 51–62.
75. Rorsman, B., Hagnell, O. and Lanke, J. (1986) Prevalence and incidence of senile and multi-infarct dementia in the Lundby study: a comparison between the time periods 1947–1957 and 1957–1972. Neuropsychobiology. 15, 122–129.
76. Roses, A.D. (1995) Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Annals of Neurology. 38, 6–14.
77. Sayetta, R.B. (1986) Rates of senile dementia — Alzheimer's type in the Baltimore longitudinal study. Journal of Chronic Disabilities. 39, 271–286.
78. Selvin, S. (1996) Statistical analysis of epidemiologic data. Oxford University Press.
79. Severson, M.A., Smith, G.E., Tangalos, E.G., Peterson, R.C., Kokmen, E., Ivnik, R.J., Atkinson, E.J. and Kurland, L.T. (1994) Patterns and predictors of institutionalization in community-based dementia patients. Journal of the American Geriatrics Society. 42, 181–185.
80. Singleton, A., Smith, G., Gibson, A.M., Woodward, R., Perry, R.H., Ince, P.G., Edwardson, J.A. and Morris, C.M. (1998) No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease. Human Molecular Genetics. 7, 937–939.
81. Slooter, A.J.C. and Van Duijn, C.M. (1997) Genetic epidemiology of Alzheimer disease. Epidemiologic Reviews. 19, 107–119.
82. Slooter, A.J.C., Cruts, M., Kalmijn, S., Hofman, A., Breteler, M.M.B., Van Broeckhoven, C. and Van Duijn, C.M. (1998) Risk estimates of dementia by apolipoprotein E genotype from a population-based incidence study: the Rotterdam study. Archives of Neurology. 55, 964–968.
83. Stern, G., Tang, M.X., Denaro, J. and Mayeux, R. (1995) Increased risk of mortality in Alzheimer's disease patients with more advanced educational and occupational attainment. Annals of Neurology. 37, 590–595.
84. Stern, Y., Brandt, J., Albert, M., Jacobs, D.M., Liu, X., Bell, K., Marder, K., Sano, M., Albert, S., Castenada, C.D.-C., Bylsma, F., Tycko, B. and Mayeux, R. (1997) The absence of an apolipoprotein ϵ4 allele is associated with a more aggressive form of Alzheimer's disease. Annals of Neurology. 41, 615–620.
85. Strachan, T. and Read, A.P. (1999) Human molecular genetics (second edition). BIOS Scientific Publishers, Oxford.
86. Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G.S. and Roses, A.D. (1993) Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type-4 allele in late-onset Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 90, 1977–1981.
87. Subramanian, K. and Lemaire, J. (2000) Estimating adverse selection costs in a market with genetic testing for breast and ovarian cancer: the case of life insurance. To appear in Journal of Risk and Insurance.
88. Tan, K.W. (1997) The financial impact of genetic testing on annuities. M.Sc. dissertation, Heriot-Watt University. Edinburgh.
89. Tierney, M.C., Fisher, R.H., Lewis, A.J., Zorzitto, M.L., Snow, W.G., Reid, D.W. and Nieuwstraten, P. (1988) The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology. 38, 359–364.
90. Treves, T., Korczyn, A.D., Zilber, N., Kahana, E., Leibowitz, Y., Alter, M. and Schoenberg, B.S. (1986) Presenile dementia in Israel. Archives of Neurology. 43, 26–29.
91. Tsai, M-S., Tangalos, E.G., Petersen, R.C., Smith, G.E., Schaid, D.J., Kokmen, E., Ivnik, R.J. and Thibodeau, S.N. (1994) Apolipoprotein E: risk factor for Alzheimer's disease. American Journal of Human Genetics. 54, 643–649.
92. Walsh, J.S., Welch, H.G. and Larson, E.B. (1990) Survival of outpatients with Alzheimer-type dementia. Annals of Internal Medicine. 113, 429–434.
93. Warren, V., Brett, P., Macdonald, A.S., Plumb, R.H. and Read, A.P. (1999) Genetic tests and future need for long-term care in the UK: report of a Work Group of the Continuing Care Conference Genetic Tests and Long-term Care Study Group. Continuing Care Conference, London.
94. Waters, H.R. (1984) An approach to the study of multiple state models. Journal of the Institute of Actuaries. 111, 363–374.
95. Waters, H.R. and Wilkie, A.D. (1987) A short note on the construction of life tables and multiple decrement tables. Journal of the Institute of Actuaries. 114, 569–580.
96. Waters, H.R. (1991) Computational procedures for the model. Continuous Mortality-Investigation Bureau Report. 12, 79–96.